Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Analytical Biochemistry|August 6, 2013
CD86 expression as a surrogate cellular biomarker for pharmacological inhibition of the histone demethylase lysine-specific demethylase 1James T Lynch, Mark J Cockerill, James R Hitchin, et al.
Epigenomics|June 26, 2015
KDM1 histone lysine demethylases as targets for treatments of oncological and neurodegenerative diseaseTamara Maes, Cristina MascarĂ³, Alberto Ortega, et al.
BMC Cancer|October 29, 2021
Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activityMark S Williams, Naseer J Basma, Fabio M R Amaral, et al.
Cell|October 22, 2005
The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesisAkihiko Yokoyama, Tim C P Somervaille, Kevin S Smith, et al.
Genes & Development|October 19, 2007
Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potentialPiu Wong, Masayuki Iwasaki, Tim C P Somervaille, et al.
Cancer Research|April 22, 2010
The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expressionPiu Wong, Masayuki Iwasaki, Tim C P Somervaille, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2017
Development and evaluation of 4-(pyrrolidin-3-yl)benzonitrile derivatives as inhibitors of lysine specific demethylase 1Daniel P Mould, Ulf Bremberg, Allan M Jordan, et al.
Molecular Biology Reports|September 26, 2020
EVI1 oncoprotein expression and CtBP1-association oscillate through the cell cycleRoberto Paredes, Marion Schneider, Stella Pearson, et al.
Pageof 8